These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 7492626

  • 41. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner.
    Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ.
    Blood; 2001 May 15; 97(10):3075-85. PubMed ID: 11342433
    [Abstract] [Full Text] [Related]

  • 42. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H, Vita M, Sallam H, Tehranchi R, Nilsson C, Sidén A, Hassan Z.
    Cancer Chemother Pharmacol; 2007 Nov 15; 60(6):841-9. PubMed ID: 17318617
    [Abstract] [Full Text] [Related]

  • 43. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM.
    Exp Hematol; 1989 Feb 15; 17(2):191-7. PubMed ID: 2463933
    [Abstract] [Full Text] [Related]

  • 44. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS, Hughes NK, Hulette BC, Noblitt L.
    J Leukoc Biol; 1991 Dec 15; 50(6):580-6. PubMed ID: 1940611
    [Abstract] [Full Text] [Related]

  • 45. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH, Talpaz M, Deisseroth AB, Estrov Z.
    Leukemia; 1996 May 15; 10(5):757-65. PubMed ID: 8656668
    [Abstract] [Full Text] [Related]

  • 46. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
    Keller JR, Bartelmez SH, Sitnicka E, Ruscetti FW, Ortiz M, Gooya JM, Jacobsen SE.
    Blood; 1994 Oct 01; 84(7):2175-81. PubMed ID: 7919333
    [Abstract] [Full Text] [Related]

  • 47. Cytokine stimulation of human fetal hematopoietic cells.
    Ek S, Westgren M, Markling L, Kjeldgaard A, Ringdén O.
    Fetal Diagn Ther; 1996 Oct 01; 11(5):318-25. PubMed ID: 8894626
    [Abstract] [Full Text] [Related]

  • 48. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells.
    Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li ZH, Lyman SD.
    Exp Hematol; 1995 Sep 01; 23(10):1121-9. PubMed ID: 7544740
    [Abstract] [Full Text] [Related]

  • 49. Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages.
    Yamamoto Y, Klein TW, Friedman H.
    Infect Immun; 1997 Mar 01; 65(3):1077-82. PubMed ID: 9038318
    [Abstract] [Full Text] [Related]

  • 50. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar 01; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 51. Chemokines/intercrines and central regulation of feeding.
    Plata-Salamán CR, Borkoski JP.
    Am J Physiol; 1994 May 01; 266(5 Pt 2):R1711-5. PubMed ID: 7515592
    [Abstract] [Full Text] [Related]

  • 52. Macrophage inflammatory protein-1alpha and interferon-inducible protein 10 inhibit synergistically induced growth factor stimulation of MAP kinase activity and suppress phosphorylation of eukaryotic initiation factor 4E and 4E binding protein 1.
    Aronica SM, Gingras AC, Sonenberg N, Cooper S, Hague N, Broxmeyer HE.
    Blood; 1997 May 15; 89(10):3582-95. PubMed ID: 9160663
    [Abstract] [Full Text] [Related]

  • 53. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY.
    J Immunol; 1983 Sep 15; 131(3):1300-5. PubMed ID: 6193183
    [Abstract] [Full Text] [Related]

  • 54. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR.
    Stem Cells; 1997 Sep 15; 15(1):63-72. PubMed ID: 9007224
    [Abstract] [Full Text] [Related]

  • 55. CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).
    Broxmeyer HE, Lu L, Hangoc G, Cooper S, Hendrie PC, Ledbetter JA, Xiao M, Williams DE, Shen FW.
    J Exp Med; 1991 Aug 01; 174(2):447-58. PubMed ID: 1713254
    [Abstract] [Full Text] [Related]

  • 56. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec 01; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 57. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S.
    Haematologica; 1992 Dec 01; 77(2):142-5. PubMed ID: 1383105
    [Abstract] [Full Text] [Related]

  • 58. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo.
    Mantel C, Luo Z, Canfield J, Braun S, Deng C, Broxmeyer HE.
    Blood; 1996 Nov 15; 88(10):3710-9. PubMed ID: 8916935
    [Abstract] [Full Text] [Related]

  • 59. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 60. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D, Lemoine FM, Najman A, Guigon M.
    Exp Hematol; 1995 Jun 15; 23(6):551-6. PubMed ID: 7539383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.